Sports Injury or Something Worse?
Published on
Read a case study about a 13-year-old girl with progressively worsening knee pain, illustrating a typical presentation of a child with a primary bone malignancy.
Published on
Read a case study about a 13-year-old girl with progressively worsening knee pain, illustrating a typical presentation of a child with a primary bone malignancy.
Published on
CHOP neuroblastoma researchers have detailed how cancer-driving mutations evolve during chemotherapy, and they aim to exploit this knowledge to design better treatments for children.
Published on
Peter C. Adamson, MD, of The Children’s Hospital of Philadelphia’s Division of Oncology, is the only pediatric oncologist to currently serve on the National Cancer Advisory Board.
Published on
The American Thyroid Association released its first guidelines for evaluating and managing thyroid nodules and thyroid cancer in children.
Published on
Margaret Foti, PhD, MD (hc), chief executive officer (CEO) of the American Association for Cancer Research (AACR), has been recognized with the Children’s Champion Award for her outstanding pediatric cancer advocacy efforts.
Published on
Delving into the world of the extremely small, CHOP researchers are exploring how nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma.
Published on
The history of our understanding and approach to cancer are at the center of CANCER: THE EMPEROR OF ALL MALADIES. The documentary will air in three parts on March 30, 31 and April 1 at 9 p.m. ET on PBS, with the final chapter featuring CHOP.
Published on
The FDA approved Unituxin™ (dinutuximab), which is just the third drug in history to receive initial approval for treatment of pediatric cancer. It is the first immunotherapy drug for children with cancer.
Published on
At the invitation of the White House, CHOP sent two guests to President Barack Obama’s Precision Medicine Initiative announcement on Jan. 30, 2015: CEO Steven M. Altschuler, MD, and 9-year-old patient Emily Whitehead, now cancer-free due to a personalized treatment called T cell therapy.
Published on
Learn how teens being treated for cancer at CHOP are dealing with diagnosis and treatment, and what they want you to know about life with cancer.